Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

KAYCIE KLAUSING

Physician Assistants & Advanced Practice Nursing Providers Physician Assistant Medical

NPI
1790189090
CMS profile
10633208
Location
CINCINNATI, OH

General Payments · PY2021–2024

$519.94

  • Reported across 41 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$463.11

38 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $463.11 38

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Novo Nordisk AS $250.20 10
Currax Pharmaceuticals LLC $178.21 26
VIVUS LLC $19.22 1
Lilly USA, LLC $15.48 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2021 $25.61 1
PY2023 $31.22 2
PY2024 $463.11 38

Payment records · PY2024 (38)

Sorted by paying entity, then date · as published by CMS

Program year 2024 20212023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Currax Pharmaceuticals LLC $4.59 01/04/2024 Food and Beverage Undisputed 01/23/2026 1089522786 CMS
Currax Pharmaceuticals LLC $7.28 01/29/2024 Food and Beverage Undisputed 01/23/2026 1089522788 CMS
Currax Pharmaceuticals LLC $5.17 02/06/2024 Food and Beverage Undisputed 01/23/2026 1089522790 CMS
Currax Pharmaceuticals LLC $7.11 02/27/2024 Food and Beverage Undisputed 01/23/2026 1089522792 CMS
Currax Pharmaceuticals LLC $6.91 03/05/2024 Food and Beverage Undisputed 01/23/2026 1089522794 CMS
Currax Pharmaceuticals LLC $5.89 03/13/2024 Food and Beverage Undisputed 01/23/2026 1089522796 CMS
Currax Pharmaceuticals LLC $6.98 03/19/2024 Food and Beverage Undisputed 01/23/2026 1089522802 CMS
Currax Pharmaceuticals LLC $7.70 04/03/2024 Food and Beverage Undisputed 01/23/2026 1089522800 CMS
Currax Pharmaceuticals LLC $6.82 04/16/2024 Food and Beverage Undisputed 01/23/2026 1089522798 CMS
Currax Pharmaceuticals LLC $12.55 05/02/2024 Food and Beverage Undisputed 01/23/2026 1089522804 CMS
Currax Pharmaceuticals LLC $7.30 05/21/2024 Food and Beverage Undisputed 01/23/2026 1089522806 CMS
Currax Pharmaceuticals LLC $7.07 06/06/2024 Food and Beverage Undisputed 01/23/2026 1089522808 CMS
Currax Pharmaceuticals LLC $6.58 06/20/2024 Food and Beverage Undisputed 01/23/2026 1089522810 CMS
Currax Pharmaceuticals LLC $6.63 06/27/2024 Food and Beverage Undisputed 01/23/2026 1089522814 CMS
Currax Pharmaceuticals LLC $3.20 07/08/2024 Food and Beverage Undisputed 01/23/2026 1089522812 CMS
Currax Pharmaceuticals LLC $7.13 07/18/2024 Food and Beverage Undisputed 01/23/2026 1089522816 CMS
Currax Pharmaceuticals LLC $6.38 08/01/2024 Food and Beverage Undisputed 01/23/2026 1089522818 CMS
Currax Pharmaceuticals LLC $5.77 08/15/2024 Food and Beverage Undisputed 01/23/2026 1089522820 CMS
Currax Pharmaceuticals LLC $6.72 08/30/2024 Food and Beverage Undisputed 01/23/2026 1089522824 CMS
Currax Pharmaceuticals LLC $5.32 09/12/2024 Food and Beverage Undisputed 01/23/2026 1089522822 CMS
Currax Pharmaceuticals LLC $8.60 10/01/2024 Food and Beverage Undisputed 01/23/2026 1089522826 CMS
Currax Pharmaceuticals LLC $8.83 10/22/2024 Food and Beverage Undisputed 01/23/2026 1089522828 CMS
Currax Pharmaceuticals LLC $4.15 11/06/2024 Food and Beverage Undisputed 01/23/2026 1089522830 CMS
Currax Pharmaceuticals LLC $8.06 11/19/2024 Food and Beverage Undisputed 01/23/2026 1089522832 CMS
Currax Pharmaceuticals LLC $6.40 12/09/2024 Food and Beverage Undisputed 01/23/2026 1089522834 CMS
Currax Pharmaceuticals LLC $9.07 12/19/2024 Food and Beverage Undisputed 01/23/2026 1089522836 CMS
Lilly USA, LLC $15.48 02/13/2024 Food and Beverage Undisputed 01/23/2026 1135759402 CMS
Novo Nordisk Inc $16.59 01/24/2024 Food and Beverage Undisputed 01/23/2026 1100304501 CMS
Novo Nordisk Inc $13.50 02/20/2024 Food and Beverage Undisputed 01/23/2026 1100654151 CMS
Novo Nordisk Inc $120.81 03/06/2024 Food and Beverage Undisputed 01/23/2026 1100315996 CMS
Novo Nordisk Inc $3.13 04/10/2024 Food and Beverage Undisputed 01/23/2026 1100559809 CMS
Novo Nordisk Inc $10.60 06/13/2024 Food and Beverage Undisputed 01/23/2026 1100272458 CMS
Novo Nordisk Inc $19.40 08/15/2024 Food and Beverage Undisputed 01/23/2026 1100461290 CMS
Novo Nordisk Inc $8.29 08/27/2024 Food and Beverage Undisputed 01/23/2026 1100237344 CMS
Novo Nordisk Inc $20.49 10/24/2024 Food and Beverage Undisputed 01/23/2026 1100359072 CMS
Novo Nordisk Inc $21.93 11/19/2024 Food and Beverage Undisputed 01/23/2026 1100445225 CMS
Novo Nordisk Inc $15.46 12/19/2024 Food and Beverage Undisputed 01/23/2026 1100369261 CMS
VIVUS LLC $19.22 08/13/2024 Food and Beverage Undisputed 01/23/2026 1129420255 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2021, 2023, 2024
Source files
Dataset page · Bulk file · PY2021 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.